JP2017528715A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528715A5 JP2017528715A5 JP2017513624A JP2017513624A JP2017528715A5 JP 2017528715 A5 JP2017528715 A5 JP 2017528715A5 JP 2017513624 A JP2017513624 A JP 2017513624A JP 2017513624 A JP2017513624 A JP 2017513624A JP 2017528715 A5 JP2017528715 A5 JP 2017528715A5
- Authority
- JP
- Japan
- Prior art keywords
- hba1c
- fraction
- red blood
- sample
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000003743 erythrocyte Anatomy 0.000 claims description 54
- 210000004027 cell Anatomy 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 34
- 239000000523 sample Substances 0.000 claims description 29
- 102000001554 Hemoglobins Human genes 0.000 claims description 20
- 108010054147 Hemoglobins Proteins 0.000 claims description 20
- 239000013643 reference control Substances 0.000 claims description 17
- 230000001413 cellular effect Effects 0.000 claims description 6
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical group C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 claims description 4
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 210000001995 reticulocyte Anatomy 0.000 claims description 4
- -1 HbA1c Proteins 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 239000013068 control sample Substances 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000975 dye Substances 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462049970P | 2014-09-12 | 2014-09-12 | |
| US62/049,970 | 2014-09-12 | ||
| US201462059684P | 2014-10-03 | 2014-10-03 | |
| US62/059,684 | 2014-10-03 | ||
| PCT/US2015/049797 WO2016040870A1 (en) | 2014-09-12 | 2015-09-11 | Systems and methods to determine the age of cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017528715A JP2017528715A (ja) | 2017-09-28 |
| JP2017528715A5 true JP2017528715A5 (enExample) | 2018-09-27 |
Family
ID=54238558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017513624A Ceased JP2017528715A (ja) | 2014-09-12 | 2015-09-11 | 細胞齢を決定するシステムと方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10739357B2 (enExample) |
| EP (1) | EP3191848A1 (enExample) |
| JP (1) | JP2017528715A (enExample) |
| CN (1) | CN106716138B (enExample) |
| WO (1) | WO2016040870A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3013360B1 (fr) * | 2013-11-19 | 2015-12-04 | Snecma | Procede integre de frittage pour microfissuration et tenue a l'erosion des barrieres thermiques |
| SG11201908847TA (en) * | 2017-03-31 | 2019-10-30 | Life Technologies Corp | Apparatuses, systems and methods for imaging flow cytometry |
| JP7254916B2 (ja) * | 2018-10-26 | 2023-04-10 | アボット ダイアベティス ケア インコーポレイテッド | 生理学的パラメータ分析のための方法、デバイスおよびシステム |
| CA3157672A1 (en) | 2019-11-25 | 2021-06-03 | Abbott Diabetes Care Inc. | Methods, devices, and systems for physiological parameter analysis |
| JP2021103139A (ja) * | 2019-12-25 | 2021-07-15 | ソニーグループ株式会社 | 情報処理装置、粒子測定装置、粒子測定システム、粒子分取装置、粒子分取システム、情報処理方法、及び情報処理プログラム |
| CN112305207B (zh) * | 2020-10-20 | 2023-03-10 | 上海交通大学 | 基于HbA1c和血糖浓度为传感变量的红细胞平均寿命检测方法 |
| WO2024094854A1 (en) * | 2022-11-03 | 2024-05-10 | Institut National de la Santé et de la Recherche Médicale | Method for determining the relative age of red blood cells |
| WO2025210140A1 (en) * | 2024-04-04 | 2025-10-09 | Institut National de la Santé et de la Recherche Médicale | Method for determining the age of red blood cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE141690T1 (de) * | 1991-04-08 | 1996-09-15 | Chronomed Inc | Verfahren zur analyse der glykierung von hämoglobin |
| US7541190B2 (en) * | 2005-02-07 | 2009-06-02 | Beckman Coulter, Inc. | Method of measurement of cellular hemoglobin |
| US7534618B2 (en) * | 2005-10-28 | 2009-05-19 | Hewlett-Packard Development Company, L.P. | Systems and methods for measuring glycated hemoglobin |
| US8481323B2 (en) * | 2005-10-28 | 2013-07-09 | Hewlett-Packard Development Company, L.P. | Systems and methods for measuring glycated hemoglobin |
| US7968279B2 (en) * | 2008-08-13 | 2011-06-28 | Beckman Coulter, Inc. | Reference control for cell by cell analysis |
| EP2433140B1 (en) * | 2009-05-20 | 2015-02-11 | Relia Diagnostic Systems, Inc. | Systems and methods for determining the percentage of glycated hemoglobin |
-
2015
- 2015-09-11 US US15/510,612 patent/US10739357B2/en active Active
- 2015-09-11 WO PCT/US2015/049797 patent/WO2016040870A1/en not_active Ceased
- 2015-09-11 CN CN201580048799.4A patent/CN106716138B/zh active Active
- 2015-09-11 JP JP2017513624A patent/JP2017528715A/ja not_active Ceased
- 2015-09-11 EP EP15772101.0A patent/EP3191848A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528715A5 (enExample) | ||
| Vinholt | The role of platelets in bleeding in patients with thrombocytopenia and hematological disease | |
| Patel et al. | Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease | |
| Hu et al. | Red blood cell distribution width is a potential prognostic index for liver disease | |
| Urrechaga et al. | Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis | |
| Yong et al. | The presence of diabetes and higher HbA1c are independently associated with adverse outcomes after surgery | |
| Cauthen et al. | Progressive rise in red cell distribution width is associated with disease progression in ambulatory patients with chronic heart failure | |
| Lazarova et al. | Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience | |
| Peerschke et al. | Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer | |
| Urrechaga et al. | Improvement in detecting sepsis using leukocyte cell population data (CPD) | |
| Botteri et al. | Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer | |
| Meintker et al. | Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients | |
| Sandau et al. | Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers | |
| Franck et al. | Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis | |
| JP2018517892A5 (enExample) | ||
| US11340228B2 (en) | Methods for analyzing rare circulating cells | |
| Ng et al. | Evaluation of the new red cell parameters on Beckman Coulter DxH800 in distinguishing iron deficiency anaemia from thalassaemia trait | |
| Ibrahim et al. | Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection | |
| Cannizzo et al. | The role of CD19 and CD27 in the diagnosis of multiple myeloma by flow cytometry: a new statistical model | |
| Davis et al. | Determination of optimal replicate number for validation of imprecision using fluorescence cell‐based assays: Proposed practical method | |
| Carli et al. | Frequency of DEA 1 antigen in 1037 mongrel and PUREBREED dogs in ITALY | |
| Shteinshnaider et al. | Prognostic significance of changes in red cell distribution width in an internal medicine ward | |
| EP2717681A1 (en) | System and method of cytomic vascular health profiling | |
| MX2020009705A (es) | Metodos para la deteccion del riesgo de enfermedad renal cronica en un sujeto y metodo implementado por computadora. | |
| Ahluwalia et al. | Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra‐abdominal veins in the ethnic Indian population–results from FLAER‐based flowcytometry screening |